Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

April 17, 2012

Primary Completion Date

June 1, 2014

Study Completion Date

May 27, 2018

Conditions
Breast Cancer
Interventions
DRUG

Nab-paclitaxel

Trial Locations (13)

15006

Complejo Hospitalario Universitario A Coruña, A Coruña

20012

Instituto Oncológico de Guipúzcoa, Donostia / San Sebastian

23007

Complejo Hospitalario de Jaén, Jaén

28007

Hospital General Universitario Gregorio Marañón, Madrid

28046

Hospital La Paz, Madrid

30008

Hospital Universitario Morales Meseguer, Murcia

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

45004

Hospital Virgen de la Salud, Toledo

46009

Instituto Valenciano de Oncología, Valencia

50009

Hospital Miguel Servet, Zaragoza

08208

Corporación Sanitaria Parc Taulí, Sabadell

08036

Hospital Clinic i Provincial, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER